ProfileGDS4177 / 207231_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 23% 19% 60% 39% 43% 30% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated11.8623
GSM603099KU-812 non-treated10.2319
GSM603098KCL-22 Imatinib-treated52.160
GSM603097KCL-22 non-treated20.1639
GSM603102JURL-MK1 Imatinib-treated25.0243
GSM603101JURL-MK1 non-treated15.1930